These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17030461)

  • 21. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
    Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis.
    Nordfors K; Haapasalo J; Korja M; Niemelä A; Laine J; Parkkila AK; Pastorekova S; Pastorek J; Waheed A; Sly WS; Parkkila S; Haapasalo H
    BMC Cancer; 2010 Apr; 10():148. PubMed ID: 20398423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carbonic anhydrase IX up-regulation is associated with adverse clinicopathologic and biologic factors in neuroblastomas.
    Dungwa JV; Hunt LP; Ramani P
    Hum Pathol; 2012 Oct; 43(10):1651-60. PubMed ID: 22436629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
    Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
    Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
    Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
    PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical reevaluation of carbonic anhydrase IX (CA IX) expression in tumors and normal tissues.
    Luong-Player A; Liu H; Wang HL; Lin F
    Am J Clin Pathol; 2014 Feb; 141(2):219-25. PubMed ID: 24436269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation.
    Saarnio J; Parkkila S; Parkkila AK; Haukipuro K; Pastoreková S; Pastorek J; Kairaluoma MI; Karttunen TJ
    Am J Pathol; 1998 Jul; 153(1):279-85. PubMed ID: 9665489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
    Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
    Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase IX expression in prostate cancer.
    Smyth LG; O'Hurley G; O'Grady A; Fitzpatrick JM; Kay E; Watson RW
    Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):178-81. PubMed ID: 20038959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stromal expression of carbonic anhydrase IX in esophageal cancer.
    Jomrich G; Jesch B; Birner P; Schwameis K; Paireder M; Asari R; Schoppmann SF
    Clin Transl Oncol; 2014 Nov; 16(11):966-72. PubMed ID: 24737069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines.
    Hunakova L; Bodo J; Chovancova J; Sulikova G; Pastorekova S; Sedlak J
    Neoplasma; 2007; 54(6):541-8. PubMed ID: 17949239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
    Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
    Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carbonic anhydrase IX: a promising diagnostic and prognostic biomarker in breast carcinoma.
    Furjelová M; Kovalská M; Jurková K; Horáček J; Carbolová T; Adamkov M
    Acta Histochem; 2014 Jan; 116(1):89-93. PubMed ID: 23816158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
    Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
    Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.